GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
59.85
-0.31 (-0.52%)
Jun 12, 2026, 4:00 PM EDT - Market closed
GRAIL Revenue
GRAIL had revenue of $40.79M in the quarter ending March 31, 2026, with 28.11% growth. This brings the company's revenue in the last twelve months to $156.12M, up 19.44% year-over-year. In the year 2025, GRAIL had annual revenue of $147.17M with 17.18% growth.
Revenue (ttm)
$156.12M
Revenue Growth
+19.44%
P/S Ratio
16.45
Revenue / Employee
$171,560
Employees
910
Market Cap
2.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 147.17M | 21.58M | 17.18% |
| Dec 31, 2024 | 125.60M | 32.49M | 34.90% |
| Dec 31, 2023 | 93.11M | 37.56M | 67.61% |
| Jan 1, 2023 | 55.55M | 40.94M | 280.17% |
| Jan 2, 2022 | 14.61M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| RadNet | 2.14B |
| Sotera Health Company | 1.19B |
| NeoGenomics | 745.97M |
| OPKO Health | 581.12M |
| Veracyte | 541.74M |
| GeneDx Holdings | 442.68M |
| CareDx | 412.82M |
| Twist Bioscience | 409.48M |
GRAL News
- 20 hours ago - GRAL Breaking News: GRAIL, Inc. Sued for Securities Fraud after Trial Results Lead to 50% Stock Drop – Investors Notified to Contact BFA Law - Business Wire
- 2 days ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 4, 2026 in Grail, Inc. Lawsuit - GRAL - PRNewsWire
- 3 days ago - GRAIL, INC. (GRAL) INVESTOR ALERT Investors With Large Losses in GRAIL, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewsWire
- 4 days ago - GRAIL Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 8 days ago - Grail initiated with a Neutral at Goldman Sachs - TheFly
- 10 days ago - GRAIL Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 11 days ago - Grail assumed with a Peer Perform at Wolfe Research - TheFly
- 11 days ago - Grail falls -15.6% - TheFly